G907-0191 Screening compound: 1-[(1-benzyl-1H-indol-2-yl)methyl]-N-[(2-ethoxyphenyl)methyl]piperidine-4-carboxamide

G907-0191 Screening compound: 1-[(1-benzyl-1H-indol-2-yl)methyl]-N-[(2-ethoxyphenyl)methyl]piperidine-4-carboxamide
G907-0191 Screening compound: 1-[(1-benzyl-1H-indol-2-yl)methyl]-N-[(2-ethoxyphenyl)methyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G907-0191
1-[(1-benzyl-1H-indol-2-yl)methyl]-N-[(2-ethoxyphenyl)methyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G907-0191

Molecular Formula

C31H35N3O2 (C31 H35 N3 O2)

Compound Name

1-[(1-benzyl-1H-indol-2-yl)methyl]-N-[(2-ethoxyphenyl)methyl]piperidine-4-carboxamide

IUPAC name

1-[(1-benzyl-1H-indol-2-yl)methyl]-N-[(2-ethoxyphenyl)methyl]piperidine-4-carboxamide

SMILES

CCOc1c(CNC(C2CCN(Cc3cc(cccc4)c4n3Cc3ccccc3)CC2)=O)cccc1

InChI

InChI=1S/C31H35N3O2/c1-2-36-30-15-9-7-13-27(30)21-32-31(35)25-16-18-33(19-17-25)23-28-20-26-12-6-8-14-29(26)34(28)22-24-10-4-3-5-11-24/h3-15,20,25H,2,16-19,21-23H2,1H3,(H,32,35)

InChI Key

GIHDEFNYYDGSSV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27167339

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.64

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.374

Distribution Coefficient, logD

3.276

Water Solubility, LogSw

-5.93

Polar Surface Area

36.530

Acid Dissociation Constant (pKa)

12.56

Base Dissociation Constant (pKb)

9.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.30

G907-0191 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anti-infective Library (19449 compounds)

CNS Targets (44014 compounds)

CNS targets activity set (6557 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with G907-0191 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G907-0191?
Check Price and Availability of G907-0191, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G907-0191 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G907-0191
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G907-0191
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G907-0191 available by request